james_davis_nicoll: (Default)
[personal profile] james_davis_nicoll


Six works new to me: four fantasy, one horror, and one SF (also ttrpg). Four are arguably series.

Books Received, November 29 — December 5



Poll #33929 Books Received, November 29 — December 5
Open to: Registered Users, detailed results viewable to: All, participants: 0


Which of these look interesting?

View Answers

New Edge Sword & Sorcery Magazine: Volume I, Number 5 edited by Oliver Brackenbury (December 2025)
0 (0.0%)

New Edge Sword & Sorcery Magazine: Volume I, Number 6 edited by Oliver Brackenbury (December 2025)
0 (0.0%)

New Edge Sword & Sorcery Magazine: Volume I, Number 7 edited by Oliver Brackenbury (December 2025)
0 (0.0%)

Black River Ruby by Jean Cottle (January 2026)
0 (0.0%)

The Flowers of Algorab by Nils Karlén, Kosta Kostulas, and Martin Grip (January 2026)
0 (0.0%)

Headlights by C J Leede (June 2026)
0 (0.0%)

Some other option (see comments)
0 (0.0%)

Cats!
0 (0.0%)

[syndicated profile] needlenthread_feed

Posted by Mary Corbet

Schedule Reminder: The Studio and online shop are closed from Dec 3 through December 18, and I have limited access to email. If you email and don’t hear back from me, that’s why. Please leave all non-urgent communications until after December 18th. Thanks! Blog posts will continue through Christmas as planned, though, and there are a few other scheduled posts for you, too!

Welcome to Part 6 of our current stitch-along here on Needle ‘n Thread, Twinkle, Twinkle: A Christmas Star Ornament! Today, we’re going to construct the project into an ornament. If you’re not used to finish work, it might seem daunting, but I promise you, it’s pretty easy and it’s not going to take too long.

If you’re just joining in, you’ll find all the previous installments of this stitch-along available here, in the Twinkle, Twinkle Project Index.

For members of the Needle ‘n Thread Community on Patreon, you’ve already received the PDF that covers all this information.

If you are interested in video instruction for this entire project but not interested in the monthly membership (it’s $5 for “Avid Stitcher” level), you can purchase access to the individual videos that you’d like to view. You’ll find the videos listed under the Twinkle, Twinkle Collection on my membership page, including the videos for finishing the project.

Nitty-gritty announcements are over – let the fun commence!

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Before you begin the finishing process, it’s a good idea to gather together all your supplies that you’ll need into one clean workspace. You’ll need good lighting, too, so be sure to have a task light or a sunny window at hand!

Be sure to read through the whole process before you begin working.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

For the construction of the ornament, you’ll need:

  • The embroidered project
  • Thermolam (mentioned in the original materials list)
  • Felt for the back of the ornament
  • A cut board 3 7/8″ round (4-ply mat or Bristol board work)
  • PVA glue (I use SOBO)
  • A paintbrush
  • A glue plate or tray to squeeze glue into
  • Sewing pins (larger heads are easier!)
  • Clips (like Clover Wonder Clips – I usually use the mini, but the regular size work, too
  • Fabric scissors
  • A pencil
  • A ruler
  • All-purpose white sewing thread
  • #8 crewel needle
  • Tweezers

Set aside about an hour to work on the finishing of the ornament. It may not take that long, but it’s easier to work straight through this part of the project, than to break it up in installments.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Cut the thermolam and the felt out, using the cut board as a guide.

For the felt, I trace around the board with a pencil and cut on the line. If any pencil shows, I make sure that the pencil-line side is the side turned to the inside of the ornament when I assemble it.

For the thermolam, I usually just hold the board and thermolam together and carefully cut out the thermolam.

For your embroidered piece, mark about 5/8″ away from the edge of the embroidery, all around the design area. Use the marks as a guide to cut the extra fabric off around the embroidery. You want about a 5/8″ edge all around, for turning.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Sandwich the thermolam between the board and the embroidery – the order is shown above.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Now it’s time to carefully pin the embroidery in place around the board, so that it is centered and aligned on the board.

Start at one tip of the star, and pin into the linen and into just the very edge of the board with the very tip of a pin, enough to hold the linen in place.

Then, work a tip on the opposite side of the star.

Do this all around at the star, spacing the pins out a bit, just to get the fabric situated and in place on the board.

You may have to occasionally remove a pin and re-pin, adjusting the fabric as you go.

You can slightly stretch the fabric over the thermolam and board, but you don’t want to be stretching super-tight here. You don’t want the embroidery fabric to pull into the thermolam and make a dent or pucker. You want the surface to be smooth and equal all around.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Then, work your way back around the star, from side to side, pinning between the pins.

It may seem like overkill, but pinning abundantly around the star will help ensure a nice, smooth edge.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Now, you’re going to flip the ornament over carefully and start the glueing process.

Work in small segments at a time, starting with one segment about the width of your finger or thumb, and add a thin coating of glue to the board, where you’ll be turning the fabric down onto the glue on the board. You don’t need to snip any fabric yet with the first bit that you glue down.

When you glue, do not glue near the edge of the board! Glue about 1/8″ in from the edge. This will make the sewing up of the ornament and the working of the beaded edge much, much, much easier.

Brush a thin layer of glue on, turn the fabric over onto the layer of glue, then push the fabric towards the center of the board with your finger. You might get a little glue on your fingers here – that’s ok. You can just roll it off when it dries.

After you get the first bit glued on, you can snip into the fabric. Snip either a straight line or a small inverted “V” as shown above. Snip towards the edge of the board, but not to the edge. Leave at least 1/8″ of fabric un-snipped, that wraps around the board. You don’t want the snips showing on the edge of the ornament.

The snips will help the fabric lie smoothly around the edge.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

After you take a snip or two, apply a little more glue to the next segment of board and turn the fabric onto it the same way.

Use the clips, then, to clip where you’ve glued, as shown above.

Make sure that the other side of the clips are not interfering with the front of the embroidery (especially the beads). With the Wonder Clips, we always make sure the flat side is on the front of the embroidery.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

In the past, I always pre-snipped my fabric all around, before turning and glueing. Now, I snip as I go. Sometimes, I use an inverted “V,” but sometimes, I just snip a straight line into the fabric. The idea is just to allow the fabric to lie smoothly as glue around the ornament.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Work all the way around the edge, always pushing the fabric towards the center of the board as you turn it over the edge and apply it to the glued area.

Take your time with this process! It doesn’t take a lot of time, but it’s worth doing it carefully!

Once it’s glued all around, leave it to dry well. I usually leave it for about 15 minutes or so.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Now you’ll sew the felt onto the back of the ornament.

There are two ways you can do this. You can use a “blind” ladder stitch or you can whip stitch the edge.

You won’t see the blind ladder stitch, but you have to be careful with the tension on it, because it can cause some visible ripples. It’s also a little trickier to work into the felt edge, because you’re not going all the way through the felt.

The whip stitch is easy and quick, but it has the disadvantage of being visible.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

To do the blind ladder stitch, use one strand of thread (not doubled) in the needle, knot the end, bring the thread into the fabric on the back of the ornament where it will be covered with felt (so the knot isn’t visible) and take the needle out at the ornament edge in the linen, just under the lip of the edge, facing the felt.

You’ll make a small straight stitch in the linen, then jump over the felt and make a small straight stitch on the inside side of the felt (the side facing the back of the ornament), picking up just a tiny bit of the felt and not going all the way through it.

Then jump back over to the back of the linen on the edge of the ornament, then back to the felt, and so forth – following the pattern noted by the red line in the photo above.

When you end your thread, end it as invisibly as possible between the felt and back of the ornament, and using a knot.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

For whip stitch, the principles of starting and ending the thread are the same. The stitch is simply whipped around the edge of the felt and into the linen, all around the ornament. Your stitches should be about 1/8″ into the felt. You can slant these stitches, or you can make them straight, perpendicular to the edge of the ornament.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

I prefer the blind ladder stitch.

Applying the Crystals

You can apply the flatback crystals now, or you can wait until you do the beaded edge.

On different samples, I applies the crystals at different times. On some, I applied them right after beading the background, but I found that, during the pinning and glueing process, the crystals got in the way – and I did pin so that it popped right after the fabric.

So I suggest applying either now or after beading the edge. On the rest of my samples, I applied them now. I didn’t wait until after beading the edge.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

To apply the crystal, I used the round head of a pin to pick up some glue, and, while holding the crystal with tweezers, I applied the glue to the back of the crystal.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Then, I gently set the crystal in place where I wanted it on the fabric. Don’t press it in place right away. Just gently place it, then use tweezers to make sure it’s right where you want it.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

I used the tail end of my tweezers to gently push and hold the crystal in place while the glue dried.

After a minute or so, I switched to using my finger, and just pressed gently on the crystal with my finger for a good three or more minutes, holding it in place and being certain that the glue dried and adhered.

Twinkle, Twinkle Stitch Along Part 6: Assembling the Ornament

Of course, I forgot to take a photo without the beaded edge on, so this rendition above will give you a general idea of what things should look like, if your constructed ornament is lying on your work surface in front of you.

And that’s that!

Coming Up!

We will work the decorative beaded edge together on Friday! Wooohooo!! See you then!

Like A Bridge Over Troubled Icing

Dec. 8th, 2025 02:00 pm
[syndicated profile] cakewrecks_feed

Posted by Jen

[A group of Wreckerators, some in frosting-smeared aprons, walk on stage and begin to sing...]

When they're leery

Feeling small...

When tears are in...

... their eyes,

Why not buy them all?

All on one side...

Ohhhhh
'cause spa- cing's tou- ou- ough...

[joining hands]

When friends just caaan't beee found!

[soprano solo]

I assure you, that's "Harry Potter!"

[chorus]

Why not pay me now?

I’ve a fridge full of stubbled otter:

[3-part harmony]

Why not pay me now?

 

A very happy birthday to Art Garfunkle - who we hope will forgive us - and many thanks to Liz K., Lynnette W., Paul A., Michelle S., Rachel H., Lexi, C.H., & Katie S. for helping us appreciate the sound of silence.

Vegan Lasagna

Dec. 8th, 2025 02:30 pm
[syndicated profile] budget_bytes_rss_feed

Posted by Jess Rice

I see you—standing in the grocery store line, eyeing that pack of ground beef and two kinds of cheese, wondering if tonight’s comfort food is about to wreck your budget. Go ahead and put them back, friend! This Vegan Lasagna recipe is here to save dinner (and your wallet). It’s hearty, surprisingly creamy, and packed with serious plant-based protein thanks to a powerhouse mix of tofu, lentils, and beans. You’ll get all the cozy, saucy, layered goodness of classic lasagna, just without the price tag or the meat. Trust me, this budget-friendly, dairy-free lasagna is proof that you don’t have to spend big to eat big.

Side view of a slice of vegan lasagna with a fork.

My Favorite Vegan Lasagna Recipe

Using everyday vegan staples like lentils, tofu, beans, and walnuts, this recipe is layer after layer of plant-based goodness. I make a homemade “ricotta” from tofu and cannellini beans, build a hearty meatless filling with lentils, mushrooms, sun-dried tomatoes, and walnuts, and tuck them between layers of marinara, spinach, and lasagna noodles. Everything comes together with a deep, umami flavor that makes each slice feel extra cozy and satisfying.

But what is umami, you ask? Umami is the savory “fifth taste” that makes food crave-worthy! And you don’t need meat to get umami! The tomatoes, mushrooms, and walnuts I use in this recipe bring it naturally. Even better, this whole pan lands at about 180 grams of protein total for roughly $15, which beats our already budget-friendly meat-and-cheese lasagna when you compare the price per serving. And the higher cost of meat and dairy can really make those prices jump!

All this to say, it doesn’t matter if you’re vegan, dairy-free, or just craving a lighter version of your favorite comfort food; this homemade vegan lasagna hits all the right notes.

Recipe Tips & Suggestions

  1. I like to add a little extra store-bought vegan cheese to this tofu lasagna when I have it on hand, but that stuff is expensive!! Not to mention, vegan cheeses can be polarizing, with everyone having specific brand loyalties. The creamy white beans and the touch of acid from the lemon juice really make the tofu ricotta layer my favorite part of this dish! But if you have vegan cheese on hand, feel free to add it to the tofu mixture.
  2. Give your lentils a quick check before cooking. I always check my dried lentils for debris, then rinse them well under cool water. You can also use canned lentils in this recipe. Just drain them and skip the simmering step.
  3. Let it cool for about 10 minutes before serving to help the layers set and make slicing easier.
  4. If you’re into hearty plant-based mains and have leftover ingredients, this lentil-mushroom combo is similar to what I use in my lentil meatloaf recipe. It’s perfect if you want another cozy option to keep in your rotation!
Side view of a slice of vegan lasagna on a plate.
Print Add to Collection

Vegan Lasagna

This easy Vegan Lasagna is a comforting, meatless, dairy-free recipe made with tofu ricotta, lentils, and rich marinara for a flavorful plant-based meal.
Course Main Course
Cuisine American, Italian
Total Cost $15.13 recipe / $1.26 serving
Prep Time 25 minutes
Cook Time 1 hour 20 minutes
Total Time 1 hour 45 minutes
Servings 12 servings
Calories 284kcal
Author Jess Rice

Equipment

  • 9×13 Baking Dish
  • Food Processor
  • Sauté Pan
  • Aluminum foil

Ingredients

Lentil Layer

  • 3 cups water $0.00
  • ½ cup dried brown lentils uncooked and rinsed, $0.48
  • 2 tsp salt divided, $0.02
  • ¼ cup sun-dried tomatoes in oil, $1.24*
  • ¼ cup walnuts $0.62**
  • 8 oz. white mushrooms $1.94
  • 1 Tbsp reserved sun-dried tomato oil or olive oil, $0.19
  • 1 Tbsp Italian seasoning $0.52
  • 14.5 oz. can petite diced tomatoes in juices, $0.96

Vegan Lasagna Ingredients

  • 16 oz. lasagna noodles $1.84
  • 1 tsp olive oil $0.06
  • 23 oz. marinara sauce of your choice, $1.67***
  • 1 cup fresh spinach tightly packed, $0.37
  • 1 Tbsp fresh basil minced, $0.45
  • 1 tsp fresh parsley minced, $0.08

Tofu 'Ricotta'

  • 1 lb. extra firm tofu $2.92
  • 1 Tbsp lemon juice $0.07
  • 1 Tbsp Italian seasoning $0.52
  • 15.5 oz. can cannellini beans with liquid, $0.92
  • 4 garlic cloves $0.16
  • 1 tsp black pepper freshly cracked, $0.10

Instructions

  • Gather ingredients. Preheat oven to 375°F.
  • Cook lentils by bringing 3 cups of water, ½ cup lentils, and 1 tsp salt to a boil. Then, bring it down to a simmer for 15-20 minutes or until the lentils are cooked (not overly mushy). Strain and set aside.
  • Add sun-dried tomatoes, walnuts, and white mushrooms to a food processor.
  • Pulse repeatedly until all ingredients are processed and well-combined. The texture will be similar to what you’d see if you were to mince by hand. Stop and scrape down the sides of your food processor as needed during this process.
  • Meanwhile, cook the lasagna noodles for 8-10 minutes or until al dente. They will continue cooking in the oven! Toss with 1 tsp of olive oil and set aside, covered with a clean kitchen towel or the lid to your pasta pot.
  • Add 1 Tbsp reserve sun-dried tomato oil (or olive oil if you used dried sun-dried tomatoes), ½ tsp salt, and the mushroom mixture to a sauté pan over medium-low heat. Check on your mushrooms periodically while you complete the rest of the steps. They will release their water and then eventually reabsorb it, but keep an eye on things so they don’t burn.
  • Meanwhile, break up the block of tofu (strain excess water and give each piece a gentle squeeze over the sink, but no need to press the tofu—a little moisture is good for this recipe!) and add it to your food processor with ½ tsp salt, lemon juice, 1 Tbsp Italian herb seasoning, the entire can of white beans plus the liquid in the can, garlic cloves, and black pepper.
  • Process thoroughly until a consistently smooth ricotta-like texture forms.
  • To the sauté pan with the cooking mushroom mixture, add 1 Tbsp Italian herb seasoning, cooked lentils, and strained petite diced tomatoes. Cook for an additional 5 minutes until well-mixed and fragrant.
  • Now, it’s time to assemble your plant-based lasagna! Start by spooning some of your marinara sauce into the bottom of your 9×13” dish. You just want enough to cover the bottom; this layer can be thin.
  • Next, layer the lasagna noodles so they are just overlapping, creating a thin seam.
  • Then, scoop out half of your tofu ricotta mixture and gently spread it out evenly. It will be quite thick, so this takes a bit of finesse.
  • Spread out the spinach on top of the tofu ricotta.
  • Add another noodle layer. (Depending on the shape of your 9×13” dish, you may see a need to add an extra noodle as you get closer to the top and the opening of the dish gets wider.)
  • Add sauce. You can be more generous with the sauce now.
  • Add all of the lentil mixture to this next layer, carefully spreading it out.
  • Add noodles.
  • Add the other ½ of your tofu ricotta.
  • Add another layer of noodles and the rest of the marinara sauce.
  • Top with freshly minced parsley and basil and pop it in the oven for 40 minutes, covered with tinfoil. After 40 minutes, remove the tinfoil and bake an additional 10 minutes uncovered.

See how we calculate recipe costs here.

Notes

*If you are using dehydrated dry sun-dried tomatoes (which are typically less expensive than the kind soaked in oil), you will need to rehydrate them before using them in this recipe. I recommend rehydrating them in a small amount of boiling water (just enough to cover them, then strain) OR rehydrate them in olive oil, which you’ll want to do ahead of time so they have plenty of time to soak up the oil and soften.
**If you can’t have walnuts, swap them for another nut or seed (such as shelled sunflower seeds, pecans, or almonds, etc.) You can also leave them out and add more lentils, but I love the texture they add.
***You can use any marinara you like. Go for your favorite store-bought or homemade marinara sauce.

Nutrition

Serving: 1serving | Calories: 284kcal | Carbohydrates: 48g | Protein: 15g | Fat: 5g | Sodium: 804mg | Fiber: 8g

how to make Vegan Lasagna step-by-step photos

The ingredients to make a vegan lasagna.

Gather all of your ingredients and preheat the oven to 375°F.

Lentils cooking in a saucepan.

Prep the lentil layer: Cook the lentils by bringing 3 cups of water, ½ cup of lentils, and 1 tsp salt to a boil. Once boiling, lower the heat and let them simmer for about 15-20 minutes, or until they’re cooked but not falling apart or mushy. Drain any remaining liquid and set them aside.

Sundried tomatoes, mushrooms, and walnuts in a food processor.

Place ¼ cup sun-dried tomatoes, ¼ cup walnuts, and 8 oz. white mushrooms in a food processor.

Lentil mixture in a food processor.

Pulse several times until everything is finely chopped and evenly combined. You’re aiming for a texture similar to hand-minced vegetables. Pause to scrape down the bowl whenever needed so everything gets processed evenly.

Cooked lasagna noodles tossed in olive oil.

Cook the noodles: Meanwhile, bring a large pot of water to a boil and cook 16 oz. lasagna noodles for 8-10 minutes, or until just al dente. They’ll soften more in the oven. Toss the noodles with 1 tsp olive oil to prevent sticking, then keep them covered with a clean towel or the pot lid so they are less likely to stick together and dry out.

Lentil and vegetable mixture cooking in a sauce pan.

Sauté the mushroom mix: Warm 1 Tbsp of the reserved sun-dried tomato oil (or olive oil, if using dry-packed tomatoes) in a sauté pan over medium-low heat. Stir in ½ tsp salt and the mushroom mixture. Let it cook slowly, checking in from time to time, while you move on to the next steps. The mushrooms will release moisture, then absorb it again as they continue to cook, so keep an eye on things to avoid burning.

Tofu, white beans, and seasonings in a food processor.

Make the tofu ricotta: Meanwhile, break up 1 lb. block extra firm tofu (strain excess water and give each piece a gentle squeeze over the sink, but no need to press the tofu—a little moisture is good for this recipe!) Add the tofu to the food processor along with ½ tsp salt, 1 Tbsp lemon juice, 1 Tbsp Italian herb seasoning, the entire 15.5 oz. can of white beans with its liquid, 4 garlic cloves, and 1 tsp black pepper.

Vegan tofu ricotta in a food processor.

Process until everything blends into a smooth, ricotta-like mixture with no lumps.

Lentils, tomatoes, and seasonings in a sauce pan.

Finish the lentil layer: Add 1 Tbsp Italian herb seasoning, the cooked lentils, and 14.5 oz strained petite diced tomatoes to the sauté pan with the mushroom mixture. Cook for another 5 minutes, stirring occasionally, until everything is well combined and fragrant.

A spoon spreading marinara sauce in the bottom of a casserole dish.

Assemble the vegan lasagna: Spread a thin layer of marinara sauce across the bottom of a 9×13-inch baking dish, just enough to lightly coat the surface.

Lay down your first layer of noodles, slightly overlapping them so they form a continuous base. Then, spoon out half of the tofu ricotta and spread it gently and evenly over the noodles. The mixture is thick, so take your time.

Scatter the spinach evenly over the ricotta layer. Add another layer of noodles. Depending on your dish, you may need an extra noodle as you move upward and the pan widens.

Next, spoon on a generous amount of marinara sauce. Spread the entire lentil mixture over the sauce, smoothing it out so it’s evenly distributed.

Add another layer of noodles and spread the remaining tofu ricotta on top.

Add one final noodle layer, then cover the top with the rest of the marinara sauce. Sprinkle 1 tsp freshly minced parsley and 1 Tbsp freshly minced basil over the surface.

Finished vegan lasagna.

Bake: Cover the dish with foil and bake for 40 minutes. Remove the foil and bake for another 10 minutes to finish. Let it cool for about 10 minutes, then serve and enjoy!

Side view of a slice of vegan lasagna with a fork.

Serving Suggestions

I love serving this tofu lasagna with a bright side like my zucchini and corn salad (just skip the Parmesan to keep it vegan) and a slice of homemade garlic bread made with vegan butter. If you don’t fancy a salad, I also like a serving of sautéed green beans or roasted butternut squash to make the meal feel extra warm and cozy.

Storage & Reheating

Keep leftovers stored in an airtight container in the fridge for up to 3–4 days. Reheat individual portions in the microwave or warm them in a covered dish in the oven at 350°F until heated through.

You can also freeze this vegan lasagna for up to three months, either as a whole pan or in individual portions wrapped well and tucked into a freezer-safe container or bag. Just keep in mind that cooked tofu can become denser once frozen and thawed. The mushroom layer may also release some liquid, so freezing is best if you don’t mind some texture changes. Let it thaw overnight in the fridge before reheating.

The post Vegan Lasagna appeared first on Budget Bytes.

Perfect Days

Dec. 8th, 2025 03:03 pm
poliphilo: (Default)
[personal profile] poliphilo
 Splendid public toilets they have in Tokyo!

And reading up about the movie afterwards I find that the Nippon Foundation- which commissioned the toilets from a bunch of top architects- originally brought Wenders in to make what they thought would be a short documentary about them. However the project developed....

....And turned into a minimalist story film about a guy who cleans the toilets. While I watched it I was thinking "Ozu!" and it seems the makers were thinking "Ozu!" too. Lead actor Koji Yakusho is wonderful in what is almost a silent performance. His character Hirayama has a backstory that is hinted at but never disclosed. And why should we care about it anyway?  Once he was something else. Now he's a saint. 

"Is it a little sentimental?" I found myself wondering.

But that's my 20th century conditioning showing through.
[syndicated profile] theatlantic_health_feed

Posted by Benjamin Mazer

On the Friday after Thanksgiving, Vinay Prasad, the FDA’s top vaccine regulator, made a claim that shocked the public-health establishment. “For the first time,” he wrote in a leaked email to his staff, “the US FDA will acknowledge that COVID-19 vaccines have killed American children.” The agency had supposedly identified at least 10 children who died from getting COVID shots.

To say the email was poorly received by vaccine experts and physicians would be an understatement. Prasad’s claim provoked a rapid series of rebuttals. A response from 12 former FDA commissioners, published in The New England Journal of Medicine on Wednesday, called Prasad’s memo “a threat to evidence-based vaccine policy and public health security.” All of the potential vaccine-related deaths reported to the government, presumably including those to which Prasad referred, had already been reviewed by the agency’s staff, the former commissioners wrote, and “different conclusions” had been reached. Elsewhere, doctors and scientists declared that absolutely no evidence links COVID-19 vaccines to death in children; and that in order to suggest otherwise, Prasad and his colleagues had engaged in an “evidence-manufacturing mission,” a “dumpster dive” for shoddy data, or—worse—a campaign of lying.

Prasad is among the public-health officials who, under the leadership of Robert F. Kennedy Jr., have been systematically undermining the nation’s confidence in immunizations. Prasad has not yet offered up any documentation to support his assertion, and his count of vaccine-related deaths may well turn out to be inflated. The memo’s overheated rhetoric and lengthy recitation of political grievances also raise some doubts about his claims.

Yet there’s something troubling—and telling—in the fact that his memo has provoked people to deny even the possibility of COVID-vaccine-related deaths. The idea that mRNA-based shots have, tragically, killed a very small number of children is not far-fetched. It also doesn’t imply a catastrophic threat to public health, given that tens of millions of doses of these vaccines have safely been given out to young people. From the start of the coronavirus pandemic, lack of nuance has been a problem with public-health messaging—one that anti-vaccine advocates have made use of to great effect. Now, in a moment when public health in America is under existential threat, this insistence that no evidence exists for vaccine-related deaths risks adding to the crisis.

No public-health authorities deny that COVID shots can have some ill effects. Adverse reactions are possible with all medical interventions. The mRNA-based vaccines produced by Pfizer and Moderna, in particular, are known to cause myocarditis—inflammation of the heart—on rare occasions, especially in teenage boys and young men. The form of myocarditis that occurs after vaccination is typically far less severe than the one caused by viruses; for unclear reasons, mRNA-related cases have largely disappeared in recent years. But this condition can be deadly, and considering the hundreds of millions of mRNA doses that have been administered to Americans, even extraordinarily unlikely outcomes may well be inevitable.

[Read: ‘It feels like the CDC is over’]

In August 2021, U.S. physicians published details of a 42-year-old man’s post-vaccination death from myocarditis in The New England Journal of Medicine. Similar cases trickled in from other countries too. South Korean researchers and public-health officials, who tracked postimmunization fatalities very closely, identified a total of 21 deaths from vaccine-induced myocarditis—all in adults—during their country’s initial COVID-inoculation campaign, which reached more than 44 million people. And in 2022, one of my former instructors, the forensic pathologist James Gill, Connecticut’s chief medical examiner, found that children could also be at risk of death. Writing in a peer-reviewed journal, he and his colleagues described the cases of two teenage boys who died of heart damage after receiving their second Pfizer dose.

So why is Prasad’s allegation that a very small number of kids have died from COVID shots being treated as some unholy aberration? I reached out to Paul Offit, a former member of the CDC’s immunization advisory committee who had described the memo’s assertions as being “fairly fantastic.” He told me that although Prasad’s claim may ultimately pan out, he does not consider the published case reports definitive, nor does he believe that the shots have led to any deaths. “It’s not terribly convincing that this vaccine killed anybody,” he said.

Michael Osterholm, the director of the Center for Infectious Disease Research and Policy at the University of Minnesota, gave the same response: He doesn’t think that the COVID shots have yet been linked to any deaths, and he trusts the judgment of the officials who had first reviewed these cases. (Like Offit, he allowed for the possibility that such cases might be identified in the future.)

When I reached out to Krutika Kuppalli, an infectious-disease physician who works on vaccine safety, she told me that high-quality studies from around the world have clearly demonstrated that there isn’t any wave of mRNA-related deaths. Population-level data show no increase in mortality from the Pfizer or Moderna COVID shots. This means that if the immunizations do cause death, it happens so infrequently as to be statistically undetectable. (Abundant evidence shows that the vaccines reduce mortality from SARS-CoV-2. That statistical signal is clear as day.)

[Read: Revenge of the COVID contrarians]

But there’s a disconnect among the sort of studies cited by Kuppalli and doctors’ observations on the ground. The latter may get written up in case reports of vaccine-related deaths, and although any single finding from this literature can be debatable, that doesn’t mean it ought to be ignored. Cause-of-death determinations happen every day in medicine, based on the most likely explanation of the facts. Yet when vaccines might be involved, that standard seems to change: Suddenly, authorities demand an impossibly high level of evidence.

Experts told me that any of the published cases of death from an mRNA vaccine could have resulted from some alternative cause, such as a preexisting condition or hidden infection. True enough, but these cases were thoroughly investigated. Many of the diagnoses were confirmed by autopsy, which is considered the gold-standard diagnostic approach. The 21 Korean deaths, in particular, were verified by a panel of specialists in cardiology, infectious disease, and epidemiology. Surely these, at least, should meet the bar for establishing a person’s cause of death—but the doctors and public-health professionals I spoke with for this story insisted that such reports don’t amount to slam-dunk proof. “These are important for hypothesis generation and mechanistic understanding,” Kuppalli said, “but they do not establish causality for death.”

Many mainstream experts have been drawing from the same playbook that COVID skeptics used at the height of the pandemic. Five years ago, they and others asked: Were thousands of American children truly getting hospitalized for COVID, or did they get hospitalized for some other reason and just happened to have COVID? Now we get a similar question: Did the teenagers who died after getting their Pfizer shots die from COVID vaccination, or did they just happen to die from something else after having been vaccinated?

The CDC itself has at times adopted this turbocharged incredulity. After Gill’s team published about the two teens, who died after receiving mRNA vaccines in the spring or summer of 2021, Tom Shimabukuro, then a high-level official in the CDC’s Immunization Safety Office, and several other agency staffers wrote a scathing letter to the journal, claiming that important facts had been omitted. They said the agency had found laboratory evidence of infection—a virus in one case and a bacterium in the other—and that at least the latter “suggested an alternate cause of death” that should have been mentioned in the paper.

[Read: Mortality numbers may have more to do with politics than science]

The CDC’s critique, however, was premised on errors so rudimentary that any trained pathologist should be able to spot them: The PCR test used to detect the virus in one case is known to be unreliable for determining a true infection, for example; the bacteria implicated in the other typically grow only after a patient is deceased. Given the flimsy reasoning behind the CDC’s rebuttal, Gill’s cases could easily be among the 10 deaths that the FDA is now touting. Yet according to a June 2025 presentation by the director of the CDC’s Immunization Safety Office, “no known deaths or cardiac transplants” were seen in individuals ages 12 to 29 with post-vaccine myocarditis from January to November 2021. Another slide said there was “no increased risk of death following mRNA COVID-19 vaccines.” (Neither the Department of Health and Human Services nor Shimabukuro responded to questions about this story.)

Some defensiveness about the data on vaccine-related harms is understandable. Anti-vaccine activists, the HHS secretary among them, have spent years stoking unfounded fears about mRNA vaccines; doing so has almost certainly resulted in otherwise preventable deaths among those who refused to get vaccinated. And it may well be that this administration’s claims about the harms from COVID shots are unfounded, and that no persuasive evidence will ever be provided. (The FDA has indicated that supporting data will be released later this month.) But given what is already known, the public-health establishment should be prepared for the alternative. Accepting and acknowledging reasonable proof of that reality would be an important part of effectively combating the government’s current vaccine skepticism. How can medical professionals discuss the favorable risk-benefit profile of these shots if they aren’t willing to acknowledge their worst risk? Denial also creates opportunities for those who want to break the system to rebuild it. In his memo, Prasad presents a very small number of allegedly catastrophic events as a revelation of such grave importance that “swift action” must be taken in regard to the COVID vaccines and the immunization approval process overall.

The possibility—perhaps the likelihood—that a handful of vaccine-related deaths occurred and were downplayed by medical authorities does not undermine the fact that COVID vaccination, on the whole, has prevented death on a massive scale. Nor does it justify sweeping changes to vaccine regulations. Rather, it suggests the need for some targeted reforms, such as improvements to the country’s vaccine-adverse-event reporting system—and also tells us that a strategy of minimizing tragic outcomes, however rare, may not be the best way to protect a vital instrument of public health.

[syndicated profile] theatlantic_health_feed

Posted by Nancy Walecki

For a decade after its discovery, CRISPR gene editing was stuck on the cusp of transforming medicine. Then, in 2023, scientists started using it on sickle-cell disease, and Victoria Gray, a  patient who lived with constant pain—like lightning inside her body, she has said—got the first-ever FDA-approved CRISPR gene-editing treatment. Her symptoms vanished; so did virtually everyone else’s in the clinical trial she was a part of.

This year, the technology has started to press beyond its next barrier. Most of the 8 million people globally who have sickle-cell disease share the same genetic mutation; treating rare disorders will require dealing with many different mutations, even within the same disease. And although rare diseases affect 30 million Americans in total, relatively few people are diagnosed with each one. Fyodor Urnov, the scientific director of UC Berkeley’s Innovative Genomics Institute (IGI), showed me a list of rare diseases and pointed to one carried by only 50 people. “Who’s going to work on a disease with 50 patients?” he asked. And even within one disorder, each person might need their own customized CRISPR treatment. Drug developers have little financial incentive to spend years and millions of dollars designing therapies that may need to be tailored to literally one person.

The technology is ready to treat at least some of these diseases, though. “There’s a whole toolbox now that can target arguably any part of the genome pretty precisely,” Krishanu Saha, a gene-editing researcher at the University of Wisconsin at Madison, told me. If researchers could build one CRISPR platform for a single disease, or even several similar ones, and tweak that template to suit each patient, they could target extremely rare disorders more quickly and economically. Maybe the first patient’s treatment for a disease takes $2 million and a year of development; by the third patient, the cost should be down to, say, $100,000 and a month of development, Urnov said, because you’ve already proved that the reused components are safe.

“We have been moving in the direction of thinking about CRISPR as a platform for some years,” Jennifer Doudna, the IGI’s founder, who shares the Nobel Prize for discovering CRISPR gene editing, told me. But, in her mind, 2025 was the first time many people understood its potential. A baby named KJ Muldoon is a big reason why.

In February, Muldoon became the first child to receive one of these customized CRISPR gene-editing treatments, tailored to fix his specific mutation. People born with his rare genetic disease, a type of urea-cycle disorder, have about a 50 percent chance of living past infancy. If they do, they live with extreme developmental delays and usually require a liver transplant. But when he was six months old, Muldoon got his bespoke treatment, and now he’s a healthy 1-year-old. His therapy was proof that custom gene-editing treatments can work and that they can be spun up relatively quickly, yet safely.

His treatment also gives scientists a chance to try the platform approach. The next child treated for a urea-cycle disorder should now be able to receive a CRISPR treatment from Muldoon’s template, tweaked to their unique DNA. CRISPR technology uses guide RNA, a molecular GPS of sorts, to send an editor protein to a particular address in someone’s DNA. Targeting a different mutation just means changing the address. Muldoon’s case put more momentum, too, behind personalized gene editing in general. The federal government recently announced two major  programs that offer funding to scientists working on personalized treatments for rare diseases. The focus now, Doudna said, is figuring out how to make customized CRISPR “available to anyone who needs it.”

For years, one of the main roadblocks has been the U.S. drug-regulatory system. Its approval processes were designed for traditional drugs that help many people, not a bespoke treatment that helps one child in Philadelphia. The FDA has considered each treatment, even for the same disease, as a different drug. Biochemically, two therapies might be the equivalent of a pizza with pepperoni and another with artichokes. But under the FDA approval process, “you go back to square one. You recertify the oven. You recertify the person who throws the disk of dough. You confirm the cheese is still safe to eat,” Urnov, who was also part of the team that designed Muldoon’s treatment, said. The FDA has been trying to change that process over the past few years, and last month, two of its top officials, Marty Makary and Vinay Prasad, announced a new drug pathway that could speed up approvals for personalized rare-disease treatments. The framework was inspired in large part by the success of Muldoon’s therapy. (The FDA did not respond to a request for comment.)

The new pathway opens the door to the platform approach that scientists have hoped to take. If researchers could prove they’d successfully treated a small number of patients for one rare genetic disease, they could continue customizing treatments for other mutations, and potentially also for similar conditions. That streamlined process could finally attract for-profit players—the best shot at actually getting these customized therapies to patients en masse, Doudna said. “If we’re able to bundle trials together so that we’re able to treat multiple related diseases without starting from scratch, that could completely change the economics of treating rare disease,” she said.

The first clinical trials in this model will begin soon. Urnov and his colleagues plan to investigate a platform for rare immune disorders; Rebecca Ahrens-Nicklas and Kiran Musunuru, the geneticists who treated Muldoon at the Children's Hospital of Pennsylvania, told me they are planning to start one this winter for children with various types of urea-cycle disorder. If all goes according to plan, another child should receive a treatment based on Muldoon’s in the near future.

Working this way does put more responsibility on scientists to test their therapies thoroughly, Ahrens-Nicklas said. Gene editing can go wrong: A treatment may accidentally alter the wrong part of a patient’s DNA, or the delivery mechanism could trigger a deadly immune reaction in their body. “If you have to treat fewer subjects in order to get that approval, you want to make sure that you’re really robustly measuring the safety on those few subjects” and communicating any risks to the wider gene-editing community, she said. But done well, these trials are a major step toward getting more custom treatments out to more people.

All of the researchers I spoke with emphasized that these are early days. Because of how the current gene-editing delivery mechanisms work, scientists are mostly limited to treating disorders in the blood and liver. And researchers are focused on single diseases, or groups of similar ones, for now. Their dream would be to have a CRISPR platform that could address many disparate disorders, but the current reality is that many, many families will still go without bespoke therapies. Muldoon’s treatment “took a team of people at both nonprofits and for-profit companies in multiple countries working at a scale I have never seen before,” Doudna said. And they changed his life. His parents weren’t sure if he’d ever be able to sit upright on his own, but recently, Muldoon took his first steps. The press has dubbed him a “miracle baby.” Now miracles like his need to become commonplace.

Just one thing: 08 December 2025

Dec. 8th, 2025 06:41 am
[personal profile] jazzyjj posting in [community profile] awesomeers
It's challenge time!

Comment with Just One Thing you've accomplished in the last 24 hours or so. It doesn't have to be a hard thing, or even a thing that you think is particularly awesome. Just a thing that you did.

Feel free to share more than one thing if you're feeling particularly accomplished!

Extra credit: find someone in the comments and give them props for what they achieved!

Nothing is too big, too small, too strange or too cryptic. And in case you'd rather do this in private, anonymous comments are screened. I will only unscreen if you ask me to.

Go!
tamaranth: me, in the sun (Default)
[personal profile] tamaranth
2025/192: The Summer War — Naomi Novik
Summer stories had a rhythm and a pattern to them, and she knew in her belly exactly how that one should have ended: with the summer lord rising healed and radiant from his bed to catch the hand of the heroic knight who had saved him... [loc. 556]

The Summer War has the beats and the ambience of the most classic fairytales: a king with three children, a curse with unexpected consequences, a bargain with the fae (in this world known as 'summerlings') that hinges on wording, a heroic princess.Read more... )

Monday Update 12-8-25

Dec. 8th, 2025 02:41 am
ysabetwordsmith: Artwork of the wordsmith typing. (typing)
[personal profile] ysabetwordsmith
These are some posts from the later part of last week in case you missed them:
Holiday Activities
Today's Cooking
Climate Change
Christmas Bird Count
Birdfeeding
Holiday Activities
Affordable Housing
Read "The Sound of Celebration"
Economics
Science
Today's Adventures
Climate Change
Philosophical Questions: Trends
Today's Cooking
Activism
Economics
Birdfeeding
Follow Friday 12-5-25: Active Communities on Dreamwidth Fall 2025 J-Z
Photos: House Yard
Today's Adventures
Activism
Art
Birdfeeding
Wildlife
Poem: "Protect the Inner Core"
Photography
Birdfeeding
Poem: "Never -- Ever -- Quit"
Self-Care Wednesday
Cuddle Party

Trauma has 45 comments. Affordable Housing has 75 comments. Robotics has 101 comments.


The 2025 Holiday Poetry Sale will run Monday, December 15 through Friday 19. This is a good place to spend holiday money or buy a gift for a fellow bookworm. \o/


Winterfaire 2025 is now open! List a Booth for anything you sell that would make good holiday gifts, or comment with what you're shopping for to crowdsource ideas. There are links to two similar shopping events online. if you know others, please pass the word.


"An Inkling of Things to Come" belongs to Polychrome: Shiv. It has 44 new verses and needs $72 to be complete. Shiv and his classmates discuss magical weather, magical geography, natural resources, plants and animals, history, and other aspects of worldbuilding.


The weather has been cold and snowy here. Seen at the birdfeeders this week: a large mixed flock of sparrows and house finches, several mourning doves, one female and two male cardinals, and a dark-eyed junco.

Monday 08/12/2025

Dec. 8th, 2025 09:47 am
dark_kana: (3_good_things_a_day official icon)
[personal profile] dark_kana posting in [community profile] 3_good_things_a_day

1) slept ok and delicious tea

2) supportive colleagues

3) getting things done this evening

Holiday Activities

Dec. 8th, 2025 12:09 am
ysabetwordsmith: Cartoon of me in Wordsmith persona (Default)
[personal profile] ysabetwordsmith
The Fragile Heart’s Guide to Surviving the Holidays

Because I know I’m not the only one facing the challenges that this time of year makes even harder. Perhaps it’s your first holiday after your divorce and you’ll be away from your kids, or you’ve been laid off in this terrible economy; perhaps anticipatory grief won’t let you forget that this will be your last Hanukkah with a beloved relative. Maybe you’re facing a scary health challenge. There are as many ways to be emotionally rocked this holiday season as there are on needles on a Christmas tree.


This article offers some good advice for treating emotional injuries over the holiday season.

Read more... )